Bevacizumab in Combination with Taxane versus Non-Taxane Containing Regimens for Advanced/Metastatic Nonsquamous Non–Small-Cell Lung Cancer: A Systematic Review

Conclusions: The outcomes between taxane and non-taxane regimens when given in combination with bevacizumab for patients with nonsquamous non–small-cell lung cancer are comparable.
Source: Journal of Thoracic Oncology - Category: Cancer & Oncology Tags: State of the Art: Concise Review Source Type: research